Health

Results: 6505-6516 of 9357

Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms

European Medicines Agency Accepts Deciphera’s Marketing Authorization Application for Vimseltinib for Treatment of Patients with Tenosynovial Giant Cell Tumor (TGCT)

Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout

BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer

PR Newswire associated0

Windrose Consulting Group Announces the appointment of Jose Galan as a Partner, to continue its growth as a leader in Global Pricing & Market Access Strategy Services

PR Newswire associated0

Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease

Diamyd Medical receives second U.S. FDA Fast Track designation for Diamyd® - for the prevention of Type 1 Diabetes

Implantica launches RefluxStop™ advanced education program in Spain

Enzymatica's Board of Directors updates the financial targets

NEJM publishes ALTUVOCT® phase 3 XTEND-Kids results highlighting treatment potential for children with severe haemophilia A

Enzymatica's Board of Directors decides on a new rights issue of approximately SEK 130 million

Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update